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phy, venous plasma sampling, and pelvic gadolinium-
enhanced magnetic resonance imaging revealed a 4-cm extra-
adrenal actively secreting mass consistent with a pheochro-
mocytoma, situated just above the level of the aortic
bifurcation between the aorta and inferior vena cava (Fig 1).
Echocardiography revealed a minimally dilated left ventri-
cle with an ejection fraction of 60%. Angiography demon-
strated proximal stenoses of greater than 80% in the left ante-
rior descending artery, its first diagonal branch, and the first
obtuse marginal artery. In view of the significant coronary
artery disease and unstable functioning pheochromocytoma,
we decided to perform off-pump CABG before removing the
pheochromocytoma and thus avoid CPB. 
Preoperative preparation included administering oral phe-
noxybenzamine 10 mg 3 times a day for 2 weeks before the
operation, along with atenolol 25 mg once a day once ade-
quate α-blockade had been achieved. Before induction of
anesthesia, infusions of phentolamine, sodium nitroprusside,
norepinephrine, epinephrine, and lidocaine were prepared so
that they could be administered immediately if needed to cor-
rect any acute changes in blood pressure or tachyarrhythmia.
Anesthesia was induced with etomidate and alfentanil and
maintained with 50% nitrous oxide and 0.5% to 1.5% enflu-
rane in oxygen. Vecuronium was used for muscle relaxation.
High lumbar epidural analgesia was administered with a 100-
mg bupivacaine loading dose, followed by an infusion of
0.166% bupivacaine with 1 mg of diamorphine per 6 mL of
normal saline solution, infused at a rate of 0 to 6 mL/h. In
addition to providing intraoperative and postoperative analge-
sia, the epidural would also produce a sympathetic blockade,
which would obtund any swings in blood pressure associated
with surges in catecholamine release from the tumor. The use
of anticholinergic agents, halothane, sympathomimetic neuro-
muscular blockade, and morphine was avoided.
Changes in blood pressure and pulse throughout the proce-
dure were recorded (Fig 2). After routine sternotomy and
internal thoracic artery harvesting, CABG was performed,
without instituting CPB, by means of a compression stabiliz-
Coronary artery disease requiring surgery combined with a
pheochromocytoma is a rare scenario, which presents difficul-
ties in controlling life-threatening paroxysmal alterations in
blood pressure and heart rate. All reported cases of coronary
artery bypass grafting (CABG) before removal of a pheochro-
mocytoma have involved the institution of cardiopulmonary
bypass (CPB). Severe hypertension and tachyarrhythmias have
been reported after cessation of CPB in reported cases of
CABG1,2 and mitral valve replacement.3 To our knowledge,
however, this is the first reported case of CABG in the presence
of a pheochromocytoma without the use of CPB.
Clinical summary. A 65-year-old man with a 2-year histo-
ry of angina (New York Heart Association class III) was
admitted for repeat angiography after two previous angioplas-
ties. Medical history included polycythemia rubra vera,
hypertension treated with β-blockers, and profuse sweating.
Preceding the angiogram, he was noted to have labile blood
pressure and postural hypotension. Subsequent cardiac
catheterization provoked extreme hypertensive and hypoten-
sive paroxysms. On further investigation, plasma and urinary
catecholamine levels were found to be significantly elevated
with a plasma epinephrine concentration of 208 pg/mL and a
norepinephrine concentration of 12,573 pg/mL (normal
ranges: 20-100 pg/mL and 200-500 pg/mL, respectively).
Subsequent radio-labeled metaiodobenzylguanidine scintigra-
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ing device (Access Ultima, CardioThoracic Systems, Inc,
Cupertino, Calif) to construct all coronary anastomoses. The
first graft to be carried out was a long saphenous vein graft to
the first diagonal branch. On application of the stabilizing
device, blood pressure fell slightly. This fall was no more than
was expected from our previous experience in routine off-
pump CABG operations. Once the stabilizing device was
released after completion of the anastomosis, blood pressure
rose to normal levels. This pattern was repeated again as
expected during the construction of the graft to the first
Fig 1.  Gadolinium-enhanced pelvic magnetic resonance imaging scan. A 4-cm enhanced round mass can be seen
to the left of the abdominal aorta, situated just above the level of the aortic bifurcation. This mass is consistent with
an actively secreting pheochromocytoma.
Fig 2.  Graph showing intraoperative changes in systolic and diastolic blood pressure (light gray areas) and pulse rate
(bold line) with time. Dark gray areas represent timing of graft anastomoses: D1, First diagonal branch of left ante-
rior descending artery; OM1, first obtuse marginal branch of circumflex artery; 2 proximal; two aorta-saphenous prox-
imal anastomoses; LAD, left anterior descending artery; BP, blood pressure. 
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obtuse marginal branch, also with saphenous vein. To facili-
tate grafting the circumflex territory, we opened the right
pleura wide to allow partial dislocation of the heart into the
right hemithorax to prevent significant obstruction to venous
return. Next, both aorta–saphenous vein anastomoses were
constructed with a side-biting clamp on the aorta, during
which time the blood pressure remained normal. Finally, the
left internal thoracic artery was grafted to the left anterior
descending artery with minor alteration in blood pressure,
which again resolved on removal of the stabilizing device. No
intraoperative inotropic drugs or blood pressure–lowering
agents were necessary during the procedure. 
The patient was transferred to the intensive care unit awake
and was extubated immediately. Other than the development
of atrial fibrillation, which was treated with amiodarone, the
remainder of the postoperative course was uneventful. The
patient was discharged on day 7 and was readmitted 1 month
later for removal of the pheochromocytoma, which was
uneventful.
Discussion. Pheochromocytoma is a rare condition
accounting for 0.1% of cases of hypertension. In any surgical
procedure on such a patient, the risks of cardiovascular col-
lapse, myocardial infarction, and cerebrovascular accident
are significantly elevated. On occasion, a patient requiring
removal of a pheochromocytoma also needs surgical coro-
nary revascularization. The discontinuation of CPB in such
cases has been associated with precipitation of severe hyper-
tension and tachycardia. The basis for this reaction is not
clear. It is interesting that anesthetic induction with fentanyl
was used in two reported cases.1,3 It has been suggested that
although fentanyl attenuates catecholamine release before
CPB, large increases in circulating catecholamines do occur
during CPB.4 Hypothermia, used routinely during CPB, has
also been reported to provoke catecholamine secretion by
pheochromocytoma.5 By performing off-pump CABG, we
avoided the hazardous effects of CPB on pheochromocy-
toma-induced changes in systemic vascular resistance and
hence blood pressure. The use of the off-pump technique
resulted in only minimal changes in blood pressure, which
occurred during cardiac manipulation and stabilizing device
application.
Hence, with good preoperative preparation and appropriate
anesthesia, off-pump CABG can be done safely in a patient
with pheochromocytoma, avoiding CPB. This operation can
be done before proceeding to surgical removal of the
pheochromocytoma, thus reducing the cardiac risks of the
pheochromocytoma operation.
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